microLifeMicrobiologyPeer-reviewed journal article
Exploring new Bacteroidota strains: Functional Diversity and Probiotic Characteristics
Lisa LadewigiD, Birhanu M. KinfuiD, Hanna FoktiD, H. BethgeiD, Muhammad Aammar TufailiD, John F. BainesiD, Ruth A. SchmitziD
Abstract
Bacteroidota, a diverse phylum of bacteria, are increasingly recognized for their significant contributions to host health, particularly through their antimicrobial and probiotic properties. This study investigates the functional diversity and probiotic potential of 42 new Bacteroidota strains enriched and identified from diverse hosts, including mouse ceca and human stool samples. Using 16S rRNA gene sequencing, we phylogenetically characterized the strains of the genera Bacteroides, Phocaeicola and Sphingobacterium and assessed their functional properties related to probiotic potential. The strains were evaluated concerning their ability to inhibit biofilm formation of WHO declared clinically significant pathogens, including gram-positive Staphylococcus aureus and Staphylococcus epidermidis, gram-negative Klebsiella oxytoca and Pseudomonas aeruginosa, and the eukaryotic fungus Candida albicans. Additionally, we investigated bile salt hydrolase and quorum quenching activities of the strains, key traits associated with probiotic efficacy. Our findings demonstrate that all examined Bacteroidota strains consistently exhibit a capacity to inhibit biofilm formation but to different extent. Furthermore, 14 strains showed quorum quenching activity, and 39 bile salt hydrolase activity, highlighting their probiotic potential. High biofilm inhibition as well as quorum quenching activity against both autoinducers, AHL and AI-2, were predominantly observed in Bacteroides caecimuris and Bacteroides muris, making them attractive candidates for next-generation probiotics. Overall, this study advances the field of next-generation probiotics by identifying promising candidates for therapeutic applications potentially revolutionizing approaches to microbiome-based interventions and pathogen control in clinical settings.
- organism: mouse
- organism: human
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 4
- FWCI
- 1.10
- Field percentile
- top 23%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploring Probiotic Potential: A Comparative Genomics and In Silico Assessment of Genes within the Genus Geobacillus
Ishfaq Nabi Najar, Prayatna Sharma, … Vinod Kumar·Scientific ReportsPeer-reviewed·Sep 30, 2025
- Genomic analysis of the probiotic candidate Bifidobacterium bifidum strain 900791 in the context of the B. bifidum pangenome
Juan Pablo Cárdenas, Boris Vidal‐Veuthey, … Anastasia Gutkevich·bioRxiv·Nov 10, 2025
- In-vitro pathogen inhibition: Comparing the inhibitory effects of a complex multistrain synbiotic with simple probiotics containing the yeast Saccharomyces boulardii or Lactobacillus rhamnosus bacteria
J. Piatek, H. Sommermeyer, … M. Bernatek·bioRxiv·Feb 7, 2019
- Insights into Diversity, Host-Range, and Temporal Stability of Bacteroides and Phocaeicola Prophages
Nejc Stopnišek, Stina Hedžet, … Maja Rupnik·BMC MicrobiologyPeer-reviewed·Feb 26, 2025
- Restriction of the growth and biofilm formation of ESKAPE pathogens by caprine gut-derived probiotic bacteria
P. Saini, R. Ayyanna, … B. Dey·bioRxiv·Jun 30, 2023
- Rational selection and Characterisation of bile acid (BA) metabolising species of infant origin
S. L. Long, S. A. Joyce·bioRxiv·Jun 24, 2022